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Abstract.   Dietary advice to the public about fat consumption has consistently emphasized the reduction of total fat, 
saturated fat and cholesterol.  Against a background of conflicting and changing messages about how much and what type of 
fat to consume, updated messages have emerged that emphasize the fatty acid profile of the fat, e.g. Dietary Guidelines for 
Americans, 2000.  General scientific agreement supports the recommendation to increase omega-3 fatty acid (n-3FA) 
consumption and reduce omega-6 (n-6FA) intake.  Specific quantitative recommendations for n-3FA intake, however, vary 
widely among countries and expert groups and have not yet been included among the National Academy’s Recommended 
Dietary Allowances. Unresolved questions remain about safe limits for infants, patients with certain health risks and 
interactions between n-6FA and n-3FA. Complexities about different fatty acid classes and n-3FA in particular further 
complicate communications efforts to provide concise and accurate guidance for public health. Food sources of n-3FA are 
limited and new ways of incorporating these fatty acids into foods need to be developed.  Biotechnology and food technology 
are likely to be important in enhancing n-3FA intake for all segments of the population.  Communications challenges 
presented by emerging and conflicting science about different classes of fatty acids and the health benefits of n-3FA are 
discussed in detail. 
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BACKGROUND 
 
For the past two decades or more, dietary 
recommendations regarding fat intake have consistently 
focused on reducing consumption of total fat, saturated fat 
and cholesterol as a means of lowering blood low-density 
lipoprotein (LDL) and cholesterol levels and avoiding 
excess calorie intake (Dietary Guidelines Advisory 
Committee 1985-1995, National Research Council, 1989, 
National Cholesterol Education Program 1993).  Fat has 
principally been viewed as the major culprit in overweight 
and the development of heart disease and other chronic 
diseases.  In spite of increasing awareness of the complex 
contribution to health of individual fatty acids and fatty 
acid classes, general advice to the public has emphasized 
restriction of certain classes of fatty acid – saturates and 
trans fatty acids – and limitation of calories from fat to no 
more than 30% total energy.  The health-promoting 
attributes of fats have largely been overlooked. 
Recognition of the complex and sometimes contradictory 
effects of individual fatty acids in the reduction of disease 
risk has made it exceedingly difficult to craft health 
messages for the public without enhancing the confusion 
about dietary fat that already exists (Food and Agriculture 
Organization, 1994).  As new knowledge accrues, 
guidance on dietary fat is likely to become more complex.  
The most recent edition of the Dietary Guidelines for 
Americans released in May 2000, reflects these issues 
(Dietary Guidelines Advisory Committee, 2000).  Better 
understanding of the complexities of fatty acid 
metabolism creates new opportunities to develop health 
messages that are targeted to specific audiences, focused 
on health promotion, compatible with disease prevention 
and are attuned to consumer behavior.  Health messages 
to the public encouraging consumption of n-3FA and 
tempering n-6FA intake present unique challenges and 
opportunities. 
  
Scope of Health Effects of n-3FA 
It is now clear that the n-3 long chain fatty acids 
eicosapentaenoic acid (EPA) and docosahexaenoic acid 
(DHA) have direct and indirect effects on the heart that 
are protective against heart disease.  They consistently 
lower triacyglycerol levels in normal and hyperlipidemic 
subjects, reduce platelet aggregation, usually reduce 
cholesterol levels, modestly increase LDL and high 
density lipoprotein (HDL) levels, modulate endothelial 
activation, and reduce cardiac arrhythmias (Connor 2000, 
von Schacky 2000).  In addition, they have been shown to 
reduce blood pressure, risk of sudden death, mortality 
from coronary heart disease in subjects with a previous 
myocardial infarction, modulate endothelial activation 
and improve vasodilation and blood rheology (Burr et al. 
1989, Nettleton 1995, Albert et al. 1998, De Caterina et 
al. 2000, von Schacky 2000).  In addition to their effects 
in protecting against heart disease, n-3FA act as 
immunomodulators, reducing the immune and 
inflammatory responses in immune-based diseases such 
as arthritis, psoriasis and asthma and in autoimmune 
disorders such as lupus and nephropathy (Connor 2000, 
James et al. 2000, Kremer 2000).  N-3FA may also be 
beneficial in multiple sclerosis, certain cancers, 
peroxisomal disorders and in enhancing resistance to 
infection (Nettleton 1995, Ip 1997, Gogos et al. 1998, 
Harbige 1998, Martinez et al. 2000).  A recent frontier 
where n-3FA appear beneficial is certain neuropsychiatric 
illnesses such as bipolar disorder, schizophrenia and 
depression (National Institutes of Health 1998, Stoll et al. 
1999).   
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Benefits of n-3FA in infant nutrition 
N-3FA are considered essential nutrients for fetal and 
infant development (Innis 1991, Uauy and Hoffman 
2000), although absolute requirements have not been 
defined (Gibson and Makrides 2000).  DHA is the 
required fatty acid, though infants can synthesize DHA 
from alpha-linolenic acid (ALA) and EPA. 
Recommended levels of n-3FA for infant formulae vary 
among countries and controversy exists about the 
supplementation of formulae with EPA and DHA (Scott 
et al. 1998).  All agree that at a minimum ALA is 
appropriate. Interactions with n-6FA, particularly 
arachidonic acid, are an important consideration if fatty 
acid imbalances are to be avoided. Infant nutrition may be 
enhanced if effective ways to boost the consumption of n-
3FA by pregnant and nursing women can be found.   
Recognition of the desirability of such an approach is a 
first step. 
 
 
COMMUNICATIONS ISSUES 
 
While the public has been reminded to limit fat intake to 
combat heart disease, diverse targets have been suggested.  
The Dietary Guidelines for Americans, the American 
Heart Association and others have recommended total 
energy intakes that comprise no more than 30% calories 
from fat, with saturated fat not exceeding 10% calories.  
Very low fat diets with no more than 15% calories from 
fat have been promoted as an antidote to heart disease and 
a way to reduce weight (Ornish et al. 1990).  The most 
recent edition of the Dietary Guidelines describes a diet 
limited to 30% calories from fat as “moderate.”  This 
subtle shift in language recognizes that people have 
difficulty adhering to diets with less fat and that the 
benefits of consuming less fat have been questioned.  The 
public, however, has heard conflicting messages in 
translating numbers to foods.  Examples of these mixed 
messages are shown in Table 1.  There may not be any 
good or bad foods,  but some say  there are good  and  bad  
  
Table 1.  Mixed messages about dietary fat. 
￿ Eat a low fat diet – 30% calories from fat 
￿ Very low fat diets may reverse coronary heart disease 
￿ Choose a diet moderate in fat 
￿ No good foods/bad foods 
￿ Good fats and bad fats 
￿ Vegetable fats are better than animal fats 
￿ Avoid tropical oils and shortening 
￿ Saturated fatty acids are the villains in heart disease 
￿ Trans fatty acids are worse than saturates 
￿ Margarine is better than butter 
￿ Some margarines are no better than butter 
￿ Some margarines help lower blood cholesterol 
￿ Some vegetable oils are healthier than others 
￿ Both fatty fish and lean fish are good for you 
 
Fats and that some foods are unhealthy any time (Center 
for Science in the Public Interest 2000).  Vegetable fats 
may be preferable to animal fats, but what about tropical 
vegetable oils and margarine?  If saturated fatty acids are 
the dietary villains in raising blood cholesterol levels, 
does that mean everything else is okay? 
   
The history of health messages about butter, margarine 
and spreads is illustrative of both changing science and 
consumer confusion (Katan 2000).  Originally, margarine 
was promoted as superior to butter because of its lower 
saturated fatty acid content.  Differences among 
margarines were minimized in the belief that the net 
effect would be lower saturated fatty acid intake.  With 
the realization that some margarines, particularly stick 
types, may contain tropical oils rich in saturated fatty 
acids and partially hydrogenated oils rich in trans fatty 
acids, and might actually be less healthful than butter, 
margarine became suspect (Mensink and Katan 1990, 
Lichtenstein et al. 1999).  As concern about the health 
advantages of margarines changed, emphasis shifted to 
soft margarines over stick versions, but inevitably the 
popular press returned to the comparison with butter.   
Recent product developments include margarines free of 
trans fatty acids and specialty soft margarines enhanced 
with phytosterols to control blood cholesterol levels.   
Focus solely on soft margarine still leaves open the 
question for consumers of which functionally desirable 
(solid) fats are nutritionally suitable for baking. Add the 
plethora of brand and composition differences among 
products and consumers still have reason to be confused.   
 
Similar evolution is occurring among vegetable oils 
except that the emphasis has shifted from encouraging 
consumption of high linoleic acid polyunsaturated oils to 
those with predominantly monounsaturated fatty acids.   
Simple identity may be obscured with the development of 
vegetable oils having markedly different fatty acid 
profiles from the original product, e.g. high oleic acid soy 
and sunflower oils.   Product labels alert the consumer to 
these changes, but consumers can no longer rely on the 
food source or shorthand nomenclature such as 
“vegetable” to indicate the predominant fatty acid classes.  
Diversity of fatty acid profile from the same plant source, 
e.g. soy, canola and sunflower, arguably a consumer 
benefit from biotechnology, changes the way consumer 
education messages must be crafted and demands that 
nutritionists, physicians and health educators stay abreast 
of such important changes in the food supply.  This 
oversimplistic example illustrates the difficulty faced by 
those developing simple, food-based messages for the 
general public.  Whether relatively simple dietary 
messages about fat can ever be effective or meaningful 
will need to be evaluated. 
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SCIENTIFIC ISSUES 
 
Both scientists and consumers confront new and changing 
information.  Nutritionists have responded to new data 
and emerging understanding about fatty acid metabolism 
by modifying dietary advice to the public, paying greater 
attention to the interactions and complexities of dietary 
fatty acids and putting greater effort into quantifying 
minimal and safe levels of intake.   Thus, the most recent 
Dietary Guidelines for Americans, emphasize moderate 
fat intake and consumption of monounsaturated fatty 
acids, with acknowledgment of the diverse effects among 
polyunsaturated fatty acids.  While many scientists admit 
that n-6FA intakes may be excessive, not all would 
advocate reducing their consumption.  Official mention in 
dietary advice to the public of the value of fish oils and n-
3FA has been long in arriving (Holman 1998). 
 
It may be said that nutrition scientists generally agree 
about the desirability of a low intake of saturated and 
trans fatty acids, the relatively benign effect of 
monounsaturates (Feldman 1999), and the potential for 
excess n-6FA intake to be detrimental.  There is also 
general agreement about the essentiality of n-3FA for 
infant development, the cardio-protective effects of n-
3FA and the desirability of increasing n-3FA intake by 
the general population (Simopoulos et al. 1999).  By how 
much intake should increase is unsettled and ways to 
effect such change present challenges.  For people with 
certain diseases, questions of dose, therapeutic effects and 
duration of treatment are unresolved. Consumption of n-
3FA may have contradictory effects. The benefit of n-
3FA among Type 2 diabetics whose risk of heart disease 
may be reduced perhaps at some cost to their glucose 
control is an example. Further, the inherent complexities 
about n-3FA themselves makes resolution of these 
questions particularly difficult. To what extent can ALA 
substitute for EPA and DHA?  To what extent does high 
intake of n-6FA compromise the benefit of n-3FA 
consumption? 
 
A summary of the different recommendations for n-3FA 
intake is shown in Table 2 (Simopoulos et al. 1999, Kris-
Etherton 2000).  These recommendations reflect not only  
differences in units – ratios, grams, percent total energy – 
but in quantity.  Figures shown for the U.S. have not been 
adopted officially.  Differences in recommendations 
between the U.K. and Sweden, 1.5% and 4.0% energy 
respectively, show how widely national recommendations 
can vary. 
 
Finally, it is useful to note that the emergence of new 
nutrition knowledge can have the paradoxical effect of 
refining dietary guidelines and discouraging the 
incorporation of new information into health messages 
until more precise information becomes available. It is in 
announcing and interpreting new findings for the public 
that the news media excel and public interest thus 
generated makes it compelling that health messages from 
scientists stay current. 
 
Table 2.  Recommended intakes of n-3 fatty acids
*.  
Source                  Ratio      ALA   EPA+DHA   Total         
                           n-6:n-3                                      n-3FA      
 
WHO               5-10:1 
Sweden 5:1 
Japan 2:1 
Masters               2.3:1  
                     g/day 
COMA (UK)                 -  0.2 
BNF   2.4  1.2  
NATO   -  0.8 
USA    2.2    0.65   
Canada       1.2-1.6 
Sweden      1.7 
WHO      2.8 
 
*Source: Kris-Etherton et al. 1999; WHO: World Health 
Organization, COMA: Committee on the Medical Aspects 
of Foods, BNF: British Nutrition Foundation, NATO: 
North Atlantic Treaty Organization 
 
 
FUTURE COMMUNICATIONS 
 
As awareness of the health benefits of n-3FA increases, the 
need to quantify and refine dietary fat messages will 
become more urgent. The need to diversify food sources of 
n-3FA will become pressing.   EPA and DHA are most 
concentrated in fatty fish: salmon, tuna, rainbow trout, 
sardines, mackerel, Atlantic bluefish, herring and 
anchovies, while ALA is found mainly in canola, soy and 
flaxseed oils.  Other avenues for furnishing n-3FA include 
fish oil supplements, purified fatty acids, algal sources and 
functional foods with micro-encapsulated n-3FA 
(Lovegrove et al. 1997, Newton 1998, Kris-Etherton 
2000). Genetically engineered seed oils with enhanced n-
3FA or their precursors may also be promising (Ursin 
2000). Poultry and eggs have become important sources in 
the U.S. diet because fish meal is fed to chickens and 
substantial amounts of chicken are consumed (Huang et al. 
1990, Raper and Exler 1991).  Awareness of diverse food 
sources of n-3FA will need to  increase.     
 
Acknowledgement of the differences in effectiveness 
between plant and animal sources of n-3FA may be 
important.  In order to encourage interest in and adoption 
of dietary fat guidance, it is desirable to explain the 
benefits beyond changes in blood cholesterol levels.  For 
the greater public health, it will likely become even more 
important to emphasize preventive health strategies rather 
than therapeutic approaches.  Communication about n-
3FA can also capitalize on the public’s strong interest in IIFET 2000 Proceedings 
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diet and health, organic and natural foods and innovative 
products that encourage modification of dietary habits. 
The success of the food industry in developing low fat 
foods shows that food manufacturers are responsive to 
consumer trends. Applications from genomics and 
biotechnology are promising for developing more 
healthful foods with enhanced n-3FA content.  
 
Effective communications strategies take into account 
specific audiences, the need to tailor the message to the 
audience, and simplicity.  Updated health information 
about fat, however, is complex, competes in an 
environment laden with conflicting messages and reaches 
audiences already mystified by food fats, oils and 
margarines.  Moreover, the effects of dietary change 
occur over the long term and may not be sensed by the 
individual.  Against this daunting background is the 
enduring popularity of food and the pleasure of eating, the 
power and potential of n-3FA themselves, people’s 
interest in their own health and popular fascination with 
promising science.   Surely a wager on the side of n-3FA 
is a winning bet. 
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